SEC 13F Intelligence

Finemark National Bank & Trust / LLY

Finemark National Bank & Trust’s Eli Lilly & Co Position

Does Finemark National Bank & Trust own Eli Lilly & Co (LLY)? Yes — 15.5K shares worth $17M (+0.52% of its 13F portfolio) as of Q4 2025, down from 15.6K shares the prior filed quarter.

Position Value
$17M
Q4 2025
Shares
15.5K
% of Portfolio
+0.52%
Quarters Held
29
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $3MQ4 ’18Q1 ’19: $3MQ2 ’19: $3MQ3 ’19: $3MQ4 ’19: $3MQ4 ’19Q1 ’20: $3MQ2 ’20: $4MQ3 ’20: $4MQ4 ’20: $4MQ4 ’20Q1 ’21: $4MQ2 ’21: $5MQ3 ’21: $5MQ4 ’21: $6MQ4 ’21Q1 ’22: $6MQ2 ’22: $7MQ3 ’22: $7MQ4 ’22: $7MQ4 ’22Q1 ’23: $6MQ2 ’23: $9MQ3 ’23: $11MQ4 ’23: $11MQ4 ’23Q1 ’24: $15MQ2 ’24: $17MQ3 ’24: $16MQ4 ’24: $14MQ4 ’24Q1 ’25: $15MQ2 ’25: $13MQ3 ’25: $12MQ4 ’25: $17MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202515.5K$17M+0.52%
Q3 202515.6K$12M+0.39%
Q2 202517.0K$13M+0.45%
Q1 202518.7K$15M+0.56%
Q4 202418.0K$14M+0.48%
Q3 202417.9K$16M+0.55%
Q2 202418.6K$17M+0.62%
Q1 202419.2K$15M+0.55%
Q4 202319.7K$11M+0.47%
Q3 202319.7K$11M+0.46%
Q2 202319.5K$9M+0.38%
Q1 202318.9K$6M+0.28%
Q4 202220.3K$7M+0.33%
Q3 202221.1K$7M+0.33%
Q2 202222.1K$7M+0.32%
Q1 202222.5K$6M+0.26%
Q4 202122.5K$6M+0.23%
Q3 202123.8K$5M+0.23%
Q2 202122.8K$5M+0.21%
Q1 202123.7K$4M+0.19%
Q4 202024.0K$4M+0.18%
Q3 202024.0K$4M+0.17%
Q2 202024.1K$4M+0.22%
Q1 202024.8K$3M+0.22%
Q4 201925.3K$3M+0.17%
Q3 201925.5K$3M+0.15%
Q2 201925.0K$3M+0.15%
Q1 201925.6K$3M+0.19%
Q4 201828.2K$3M+0.22%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Finemark National Bank & Trust’s full portfolio or all institutional holders of LLY.